Obesity
Showing NaN - NaN of 135
Type 2 Diabetes, Obesity, Overweight or Obesity Trial in Worldwide (Orforglipron, Insulin Glargine)
Recruiting
- Type 2 Diabetes
- +5 more
- Orforglipron
- Insulin Glargine
-
Muscle Shoals, Alabama
- +320 more
Apr 12, 2023
Obesity Trial in New York, Philadelphia (Weight loss)
Not yet recruiting
- Obesity
- Weight loss
-
New York, New York
- +3 more
Feb 17, 2023
Obesity Trial in Philadelphia (Behavioral weight loss and produce vouchers)
Recruiting
- Obesity
- Behavioral weight loss and produce vouchers
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Feb 2, 2023
Obesity, Overweight Trial in Philadelphia (Lifestyle Modification Intervention, Balanced Calorie Deficit Eating Plan, Ad Libitum
Enrolling by invitation
- Obesity
- Overweight
- Lifestyle Modification Intervention
- +2 more
-
Philadelphia, PennsylvaniaDrexel University
Jan 26, 2023
Obesity, Fruit and Vegetable Intake, Healthy Diet Trial in Philadelphia (Real-Time Incentives Group)
Completed
- Obesity
- +2 more
- Real-Time Incentives Group
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jan 10, 2023
Obesity, Food Insecurity Trial in Philadelphia (BWL+VOUCHER, BWL+HOME, Behavioral weight loss counseling (BWL))
Recruiting
- Obesity
- Food Insecurity
- BWL+VOUCHER
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Dec 19, 2022
Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Active, not recruiting
- Overweight
- Obesity
- Semaglutide
- Placebo (semaglutide)
-
Birmingham, Alabama
- +804 more
Dec 19, 2022
Obesity Trial in Philadelphia (Eating Condition)
Active, not recruiting
- Obesity
- Eating Condition
-
Philadelphia, PennsylvaniaCenter for Weight and Eating Disorders, Perelman School of Medic
Nov 8, 2022
Hypertension, Obesity Trial in Philadelphia (gamification with collaboration, gamification with competition)
Not yet recruiting
- Hypertension
- Obesity
- gamification with collaboration
- gamification with competition
-
Philadelphia, PennsylvaniaCorporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
Sep 21, 2022
Obesity Trial in Philadelphia (Behavioral Treatment, Placebo, Semaglutide 2.4 MG/0.75 ML Subcutaneous Solution [WEGOVY])
Recruiting
- Obesity
- Behavioral Treatment
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Center for Weight and Eating Disorder
Sep 19, 2022
Obesity Trial in Philadelphia (Behavioral Treatment, Placebo, Phentermine 15 MG)
Completed
- Obesity
- Behavioral Treatment
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Center for Weight and Eating Disorder
Sep 13, 2022
Coronary Artery Disease, Coronary Heart Disease, Hypertension Trial in Philadelphia (Gamification Intervention)
Not yet recruiting
- Coronary Artery Disease
- +6 more
- Gamification Intervention
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Sep 3, 2022
Obesity Trial in Philadelphia (high caloric intake, reduced caloric intake)
Active, not recruiting
- Obesity
- high caloric intake
- reduced caloric intake
-
Philadelphia, PennsylvaniaTemple University Hospital
Jul 25, 2022
B-cell Acute Lymphoblastic Leukemia, Obesity Trial in United States (IDEAL2 Intervention)
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- Obesity
- IDEAL2 Intervention
-
Los Angeles, California
- +15 more
Jun 23, 2022
Overweight, Obesity Trial in Philadelphia (Coach Share On, Group Share On, Friend/Family Share On)
Recruiting
- Overweight
- Obesity
- Coach Share On
- +6 more
-
Philadelphia, PennsylvaniaDrexel University
Jun 17, 2022
Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Active, not recruiting
- Obesity
- Semaglutide
- Placebo (semaglutide)
-
Fairhope, Alabama
- +97 more
Jun 15, 2022
Obesity, Weight Loss Trial in Philadelphia (Gamified behavioral weight loss treatment, mHealth behavioral weight loss treatment)
Not yet recruiting
- Obesity
- Weight Loss
- Gamified behavioral weight loss treatment
- mHealth behavioral weight loss treatment
-
Philadelphia, PennsylvaniaDrexel University
Jun 3, 2022
Obesity, Weight Loss Trial in Philadelphia (Standard Behavioral Weight Loss Treatment, AI-optimized Behavioral Weight Loss
Recruiting
- Obesity
- Weight Loss
- Standard Behavioral Weight Loss Treatment
- AI-optimized Behavioral Weight Loss Treatment
-
Philadelphia, PennsylvaniaDrexel University Center for Weight, Eating and Lifestyle Scienc
May 4, 2022
Overweight, Obesity Trial in United States (Semaglutide, Placebo (semaglutide), Liraglutide)
Pulmonary Disease, Chronic Obstructive, Obesity, Weight Loss Trial in United States (Lifestyle Intervention)
Completed
- Pulmonary Disease, Chronic Obstructive
- +4 more
- Lifestyle Intervention
-
Birmingham, Alabama
- +38 more
Mar 10, 2022